Hypo-fractionated Radiotherapy (HF-RT) Versus Conventionally Fractionated Radiotherapy (CF-RT) for Glioblastoma
Anticancer Research · 2023
DOI: 10.21873/anticanres.16484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Oksana Zemskova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Glioblastoma, Radiation Oncology. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.
- Department of Neurosurgery, Romodanov Neurosurgery Institute, Kyiv, Ukraine.
- Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, U.S.A.
- Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.
Zitieren
APA
Zemskova, O., Pedachenko, E., Yu, N. Y., & Rades, D. (2023). Hypo-fractionated Radiotherapy (HF-RT) Versus Conventionally Fractionated Radiotherapy (CF-RT) for Glioblastoma. Anticancer Research. https://doi.org/10.21873/anticanres.16484
Vancouver
Zemskova O, Pedachenko E, Yu NY, Rades D. Hypo-fractionated Radiotherapy (HF-RT) Versus Conventionally Fractionated Radiotherapy (CF-RT) for Glioblastoma. Anticancer Research. 2023. doi:10.21873/anticanres.16484
BibTeX
@article{Zemskova2023,
author = {Zemskova, Oksana and Pedachenko, Eugene and Yu, Nathan Y and Rades, Dirk},
title = {Hypo-fractionated Radiotherapy (HF-RT) Versus Conventionally Fractionated Radiotherapy (CF-RT) for Glioblastoma},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16484}
}
EUVIMED